Dyadic advances collaboration with israel institute for biological research (iibr) targeting bio-threats and emerging disease solutions
Jupiter, fla. and nes-ziona, israel, feb. 21, 2024 (globe newswire) -- dyadic international, inc. ("dyadic" or the "company") (nasdaq: dyai), a global biotechnology company specializing in advanced microbial platforms for protein development and bioproduction and meeting clinical needs, and israel institute for biological research (iibr) announced it has advanced its collaboration with the israel institute for biological research (iibr) and its commercial arm life science research israel (lsri), to target emerging disease solutions. this partnership aims to leverage dyadic's expertise in microbial platforms for flexible scale protein bioproduction and the iibr's antibodies and antigens discovery capabilities to develop and manufacture innovative solutions for addressing emerging diseases and potential bio-threats. through this collaboration, both parties are working towards the development of effective treatments and vaccines to combat global health challenges with the intention of future commercialization (to date, the framework is non-binding and subject to the execution of a binding agreement to be negotiated by the parties) through collaborative out-licensing initiatives.
DYAI Ratings Summary
DYAI Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission